Healthcare & Life Sciences
Response Pharmaceuticals
United Statesresponsepharmaceuticals.com
aliveseries-a
series-a
Stage
About
Response Pharmaceuticals develops novel small molecule therapeutics focused on weight management and metabolic health, including treatments for antipsychotic-induced weight gain and management of weight after discontinuing GLP-1 receptor agonists.
Explore Response Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.